News
17 days ago•4 min read
AstraZeneca's 2026 Growth Bet: The Quiet War for Cancer Patients That Big Pharma Hopes You Miss
AstraZeneca is banking on sustained **oncology demand** through 2026, but this isn't just about drugs; it's about market control and the future of **pharma technology** investment.
D
DailyWorld Editorial